MODIFIED VEGF ANTISENSE OLIGONUCLEOTIDES

摘要

Disclosed are oligonucleotides complementary to VEGF-specific nucleic aciduseful in reducing the expression of VEGF. Also disclosed are pharmaceuticalformulations containing such oligonucleotides useful for treating variousdisorders associated with neovascularization and angiogenesis.